These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15591104)

  • 21. The adenosine 2A receptor agonist ATL-146e attenuates experimental posthemorrhagic vasospasm.
    Chang CZ; Dumont AS; Simsek S; Titus BJ; Kwan AL; Kassell NF; Solenski NJ
    Neurosurgery; 2007 Jun; 60(6):1110-7; discussion 1117-8. PubMed ID: 17538386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenosine A2A receptor activation decreases reperfusion injury associated with high-flow reperfusion.
    Fiser SM; Tribble CG; Kaza AK; Long SM; Kern JA; Cassada DC; Linden J; Rieger J; Laubach VE; Matisoff A; Kron IL
    J Thorac Cardiovasc Surg; 2002 Nov; 124(5):973-8. PubMed ID: 12407381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of granulocyte cAMP-phosphodiesterase by rolipram in vivo is not sufficient to protect the canine myocardium from reperfusion injury.
    Simpson PJ; Schelm JA; Smallwood JK; Clay MP; Lindstrom TD
    J Cardiovasc Pharmacol; 1992 Jun; 19(6):987-95. PubMed ID: 1376823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective A(2A) adenosine receptor activation reduces skin pressure ulcer formation and inflammation.
    Peirce SM; Skalak TC; Rieger JM; Macdonald TL; Linden J
    Am J Physiol Heart Circ Physiol; 2001 Jul; 281(1):H67-74. PubMed ID: 11406470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limitation of myocardial reperfusion injury by AMP579, an adenosine A1/A2A receptor agonist: role of A2A receptor and Erk1/2.
    Kis A; Baxter GF; Yellon DM
    Cardiovasc Drugs Ther; 2003; 17(5-6):415-25. PubMed ID: 15107596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenosine A2A receptor activation reduces infarct size in the isolated, perfused mouse heart by inhibiting resident cardiac mast cell degranulation.
    Rork TH; Wallace KL; Kennedy DP; Marshall MA; Lankford AR; Linden J
    Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H1825-33. PubMed ID: 18757481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective A2A adenosine agonist ATL-146e attenuates acute lethal liver injury in mice.
    Odashima M; Otaka M; Jin M; Komatsu K; Wada I; Matsuhashi T; Horikawa Y; Hatakeyama N; Oyake J; Ohba R; Linden J; Watanabe S
    J Gastroenterol; 2005 May; 40(5):526-9. PubMed ID: 15942719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective adenosine A receptor agonist, ATL-146e, attenuates stress-induced gastric lesions in rats.
    Odashima M; Otaka M; Jin M; Komatsu K; Wada I; Matsuhashi T; Horikawa Y; Hatakeyama N; Oyake J; Ohba R; Linden J; Watanabe S
    J Gastroenterol Hepatol; 2005 Feb; 20(2):275-80. PubMed ID: 15683432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenosine A2A agonist reduces paralysis after spinal cord ischemia: correlation with A2A receptor expression on motor neurons.
    Cassada DC; Tribble CG; Long SM; Kaza AK; Linden J; Rieger JM; Rosin D; Kron IL; Kern JA
    Ann Thorac Surg; 2002 Sep; 74(3):846-9; discussion 849-50. PubMed ID: 12238849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuation of gastric mucosal inflammation induced by aspirin through activation of A2A adenosine receptor in rats.
    Odashima M; Otaka M; Jin M; Komatsu K; Wada I; Horikawa Y; Matsuhashi T; Hatakeyama N; Oyake J; Ohba R; Watanabe S; Linden J
    World J Gastroenterol; 2006 Jan; 12(4):568-73. PubMed ID: 16489670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic adenosine A2A agonist ameliorates ischemic reperfusion injury in the rabbit spinal cord.
    Cassada DC; Gangemi JJ; Rieger JM; Linden J; Kaza AK; Long SM; Kron IL; Tribble CG; Kern JA
    Ann Thorac Surg; 2001 Oct; 72(4):1245-50. PubMed ID: 11603444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenosine A2A analogue reduces long-term neurologic injury after blunt spinal trauma.
    Reece TB; Davis JD; Okonkwo DO; Maxey TS; Ellman PI; Li X; Linden J; Tribble CG; Kron IL; Kern JA
    J Surg Res; 2004 Sep; 121(1):130-4. PubMed ID: 15313386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacologic perturbation of neutrophils by Fluosol results in a sustained reduction in infarct size in the canine model of reperfusion.
    Forman MB; Pitarys CJ; Vildibill HD; Lambert TL; Ingram DA; Virmani R; Murray JJ
    J Am Coll Cardiol; 1992 Jan; 19(1):205-16. PubMed ID: 1729335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The preischemic combination of the sodium-hydrogen exchanger inhibitor cariporide and the adenosine agonist AMP579 acts additively to reduce porcine myocardial infarct size.
    Kristo G; Yoshimura Y; Ferraris SP; Jahania SA; Mentzer RM; Lasley RD
    J Am Coll Surg; 2004 Oct; 199(4):586-94. PubMed ID: 15454144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular pharmacology of the adenosine A1/A2-receptor agonist AMP 579: coronary hemodynamic and cardioprotective effects in the canine myocardium.
    McVey MJ; Smits GJ; Cox BF; Kitzen JM; Clark KL; Perrone MH
    J Cardiovasc Pharmacol; 1999 May; 33(5):703-10. PubMed ID: 10226856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of cell adhesion molecule expression and function on human lung microvascular endothelial cells by inhibition of phosphodiesterases 3 and 4.
    Blease K; Burke-Gaffney A; Hellewell PG
    Br J Pharmacol; 1998 May; 124(1):229-37. PubMed ID: 9630364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of inhibition of PDE4 and TNF-alpha on local and remote injuries following ischaemia and reperfusion injury.
    Souza DG; Cassali GD; Poole S; Teixeira MM
    Br J Pharmacol; 2001 Nov; 134(5):985-94. PubMed ID: 11682446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cooperative cardioprotection through adenosine A1 and A2A receptor agonism in ischemia-reperfused isolated mouse heart.
    Urmaliya VB; Pouton CW; Ledent C; Short JL; White PJ
    J Cardiovasc Pharmacol; 2010 Oct; 56(4):379-88. PubMed ID: 20930592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ATL 313, A Selective A(2A) Adenosine Receptor Agonist, Reduces Myocardial Infarct Size in a Rat Ischemia/Reperfusion Model.
    Dai W; Hale SL; Nayak R; Kloner RA
    Open Cardiovasc Med J; 2009 Nov; 3():166-72. PubMed ID: 20111666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel N6-substituted adenosine 5'-N-methyluronamides with high selectivity for human adenosine A3 receptors reduce ischemic myocardial injury.
    Tracey WR; Magee WP; Oleynek JJ; Hill RJ; Smith AH; Flynn DM; Knight DR
    Am J Physiol Heart Circ Physiol; 2003 Dec; 285(6):H2780-7. PubMed ID: 12919933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.